Sushil Beriwal, Vice President of Varian and Academic Chief of Allegheny Health Network, shared on LinkedIn:
“First time End to end AI based plan in one sec for prostate cancer ( dose prediction to deliverable plan ) validated in single institution with plan quality ( similar to better than manual or rapid plan ) and passing of QA.”
You can also read: Chemotherapy in Prostate Cancer: Current Evidence and Clinical Applications
